Psychopharmacology of ADHD in pediatrics: current advances and issues.

Neuropsychiatr Dis Treat

Michigan State University College of Human Medicine, Michigan State University/Kalamazoo Center for Medical Studies, Kalamazoo, MI, USA.

Published: April 2011

Attention deficit hyperactivity disorder (ADHD) is a neurobehavioral developmental disorder found in 3% to 8% of children and adolescents. An important part of ADHD management is psychopharmacology, which includes stimulants, norepinephrine reuptake inhibitors, alpha-2 agonists, and antidepressants. Medications with the best evidence-based support for ADHD management are the stimulants methylphenidate and amphetamine. A number of newer, long-acting stimulants are now available and a number of new medications are considered that are under current research.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695228PMC
http://dx.doi.org/10.2147/ndt.s4075DOI Listing

Publication Analysis

Top Keywords

adhd management
8
psychopharmacology adhd
4
adhd pediatrics
4
pediatrics current
4
current advances
4
advances issues
4
issues attention
4
attention deficit
4
deficit hyperactivity
4
hyperactivity disorder
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!